Following Pfizer’s acquisition, Biohaven’s valuation skyrocketed under Vlad Coric. Find out why BHVN stock’s growth potential ...
Patients with CKD have a 56% higher prevalence of severe mental health disorders such as schizophrenia, bipolar disorder, or ...
The diagnosis of major depressive disorder is based on the patient's self-reported experiences, behavior reported by relatives or friends, and a mental status examination. There is no laboratory ...
Ramadan brings unique mental health challenges; learn how clinicians and patients can navigate fasting, sleep issues and ...
2 market experts have recently issued ratings for this stock, with a consensus target price of $130.5.
The following is a summary of “Spaced Transcranial Direct Current Stimulation for Major Depression,” published in the January ...
Mice resilient to stress had more CB1 receptors in the BBB than mice with depressive-like behavior or mice not exposed to stress.
Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.
NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a generative AI software leader in clinical trial analytics, announces its funded collaboration with ...
One in 20 U.S. adults experience seasonal depression, most often in winter. UVA professor Kim Penberthy shares self-care tips ...
Objective This study aimed to investigate the incidence of overweight in patients with major depressive disorder (MDD) ...
Upping your physical activity level may lower your risk of developing neuropsychiatric diseases such as anxiety, depression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results